Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)
SCTID: 1162645008, Defined, Active
1162645008|Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)|
- en Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen
- en Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)
- en Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccination
- en 2019-ncov recombinant spike protein antigen immunisation
- en 2019-ncov recombinant spike protein antigen immunization
- en 2019-ncov recombinant spike protein antigen vaccination
- en 2019 novel coronavirus recombinant spike protein antigen immunisation
- en 2019 novel coronavirus recombinant spike protein antigen immunization
- en 2019 novel coronavirus recombinant spike protein antigen vaccination
- en Administration of sars-cov-2 recombinant spike protein antigen vaccine
- en Covid-19 recombinant spike protein antigen immunisation
- en Covid-19 recombinant spike protein antigen immunization
- en Covid-19 recombinant spike protein antigen vaccination
- en Sars-cov-2 recombinant spike protein antigen immunization
- en Sars-cov-2 recombinant spike protein antigen vaccination